Engineers Gate Manager LP

Position in NKTR — Nektar Therapeutics

CIK 1620220 NEW YORK, NY

Position in NKTR

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$1,339,165

+$454,037 QoQ

Shares Held

19,183

+55.9% QoQ

Ownership

0.056%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#112

of 239 holders

Holding Since

Mar 2020

15 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Engineers Gate Manager LP holds $195,980,910 across 162 Biotechnology names. NKTR ranks #42 (0.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INSM	INSMED Inc	126,044	$13,438,811
2	BMRN	Biomarin Pharmaceutical Inc	181,647	$10,393,841
3	ALNY	Alnylam Pharmaceuticals, Inc.	33,469	$10,075,173
4	REGN	Regeneron Pharmaceuticals, Inc.	15,918	$9,925,509
5	RPRX	Royalty Pharma plc	137,994	$7,737,323
6	EXEL	Exelixis, Inc.	110,353	$6,004,306
7	ONC	BeOne Medicines Ltd.	16,302	$4,645,580
8	VERA	Vera Therapeutics, Inc.	108,139	$4,640,244

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,339,165	19,183	+55.9%	Shares	Sole	2026-08-14
2026-03-31	$885,128	12,302	-67.0%	Shares	Sole	2026-05-15
2025-12-31	$1,576,367	37,284	+111.5%	Shares	Sole	2026-02-17
2025-09-30	$1,003,147	17,630	+31.6%	Shares	Sole	2025-11-14
2024-09-30	$17,417	13,398	-35.0%	Shares	Sole	2024-11-14
2022-12-31	$46,565	20,604	-76.3%	Shares	Sole	2023-02-14
2022-06-30	$330,436	86,957	-39.3%	Shares	Sole	2022-08-15
2022-03-31	$772,731	143,364	+835.2%	Shares	Sole	2022-05-16
2021-12-31	$207,108	15,330	-88.1%	Shares	Sole	2022-02-14
2021-06-30	$2,215,441	129,105	+346.3%	Shares	Sole	2021-08-16
2021-03-31	$578,620	28,931	-79.5%	Shares	Sole	2021-05-17
2020-12-31	$2,403,715	141,395	+311.1%	Shares	Sole	2021-02-16
2020-09-30	$570,579	34,393	+139.9%	Shares	Sole	2020-11-16
2020-06-30	$332,091	14,339	-63.3%	Shares	Sole	2020-08-17
2020-03-31	$696,667	39,029	—	Shares	Sole	2020-05-15
No filing history on record for this holder in this stock.